Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment
Krishna Koka,Amit Verma,Bilikere S Dwarakanath,Rao VL Papineni
DOI: https://doi.org/10.2147/CMAR.S351744
2022-04-12
Cancer Management and Research
Abstract:Krishna Koka, 1 Amit Verma, 2 Bilikere S Dwarakanath, 3 Rao VL Papineni 2, 4 1 Penn State University, Pennsylvania, PA, USA; 2 PACT & Health LLC, Branford, CT, USA; 3 Central Research Facility, Sri Ramachandra Institute of Higher Education and Research Porur, Chennai, India; 4 Department of Surgery, University of Kansas Medical Center, Kansas City, KS, USA Correspondence: Rao VL Papineni; Amit Verma, PACT & Health LLC, Branford, CT, USA, Tel +1 832-687-4334 ; Tel +1-919-358-2644, Email ; ; Recent technological advancements have increased the efficacy of radiotherapy, leading to effective management of cancer patients with enhanced patient survival and improved quality of life. Several important developments like multileaf collimator, integration of imaging techniques like positron emission tomography (PET) and computed tomography (CT), involvement of advanced dose calculation algorithms, and delivery techniques have increased tumor dose distribution and decreased normal tissue toxicity. Three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), stereotactic radiotherapy, image-guided radiotherapy (IGT), and particle therapy have facilitated the planning procedures, accurate tumor delineation, and dose estimation for effective personalized treatment. In this review, we present the technological advancements in various types of EBRT methods and discuss their clinical utility and associated limitations. We also reveal novel approaches of using biocompatible yttrium oxide scintillator-photosensitizer complex (YSM) that can generate X-ray induced cytotoxic reactive oxygen species, facilitating X-ray activated photodynamic therapy (XPDT (external beam) and/or iXPDT (internal X-ray source)) and azido-derivatives of 2-deoxy-D-glucose (2-DG) as agents for site-specific radiation-induced DNA damage. Keywords: radiotherapy, external beam, computed tomography, 2-deoxy-D-glucose, 2-DG, 2-azido-2-deoxy-D-glucose, 2-AZ-2-DG Radiation therapy (RT) is the widely used therapeutic modality for cancer treatment and is used either alone or in combination with other conventional modalities such as surgery, chemotherapy, immunotherapy etc. 1,2 However, RT causes collateral damage to normal tissues/organs, compromising their functioning, thereby leading to multi-organ dysfunction and death. 3,4 Patients with advanced tumors such as glioblastoma multiforme, pancreatic, and lung cancers are very difficult to treat and have very low survival rate. 5 Recent technological advances have enabled the effectiveness of RT by achieving a higher degree of local tumor control and enhanced patient survival. 5–7 RT is mainly divided into, external beam RT (EBRT), internal beam RT (IBRT) or brachytherapy, and systemic radioisotope therapy, based on the location of the radiation source. EBRT is a broad yet effective form of cancer treatment that is used in cases where there is more advanced local disease. 8,9 EBRT induces DNA damage, cell cycle arrest, cytogenetic damage, apoptosis, and senescence in cancer cells, thereby blocking the ability of cancer cells to proliferate further and undergo death. 6 While normal cells receive some radiation damage when radiation is used to treat cancer cells, normal cells are usually able to repair themselves faster than cancer cells. 10 This results in the killing of cancer cells with minimized damage to normal cells. The main types of radiation used to treat cancer are widely used photon radiation (X-rays and gamma-rays) and electron beams, which have low penetration power and are useful in treating tumors close to a body surface. Particle radiation, such as proton and neutron beams, is very effective in treating deep-seated tumors one of the newer forms of particle beam radiation, has allowed for better dose distribution in deep-seated tumors. The relative biological effectiveness (RBE) of radiation refers to the effectiveness of its cell killing (RBE). This effectiveness is dependent upon LET, fractionation rate, total dose, and radio-sensitivity of the targeted tissues and cells. 11 Radiation with low LET (X-rays and gamma-rays) results in relatively small amounts of energy being deposited. Alternatively, radiation with high LET (neutrons and protons) results in higher energy deposits in the targeted areas. The indirect DNA damage that results from radiation is due to ionization or excitation of the cell's water components. 12 Most of the cell killing in cancer and normal cells results from double-strand DNA breaks, which are irreparable. While single-strand DNA breaks exist, these are less responsible for cell deaths. The main goal of radiation therapy is to deprive cancer cells of -Abstract Truncated-
oncology